Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Liraglutide

The Effect of Liraglutide on Body Weight in Obese Subjects Without Diabetes

Novo Nordisk · Phase 2 · Completed · Enrollment 564

NCT00422058

EudraCT 2006-004481-13

ArmPopulationDoseWeeksEstimandWeight change
Lira placebo/Lira 2.4 mg/Lira 3.0 mgObesity or overweight3.0 mgn/rn/rn/r
Lira 1.2 mg/Lira 3.0 mgObesity or overweight3.0 mgn/rn/rn/r
Lira 1.8 mg/Lira 3.0 mgObesity or overweight3.0 mgn/rn/rn/r
Lira 2.4 mg/Lira 3.0 mgObesity or overweight3.0 mgn/rn/rn/r
Liraglutide 3.0 mgObesity or overweight3.0 mgn/rn/rn/r
OrlistatObesity or overweightn/rn/rn/rn/r